Abstract | BACKGROUND:
Pompe's disease, a rare, inherited deficiency of the enzyme alpha-1,4-glucosidase (GAA), is a lysosomal storage disorder. Early-onset (infantile) Pompe's disease is associated with cardiomegaly and severe myopathy and, if left untreated, will inevitably lead to death within the first 2 years of life. In juvenile Pompe's disease, progression of the disease is generally slower and involvement of the myocardium is less likely with onset at a later age. The adult form of Pompe's disease is frequently associated with a progressive proximal myopathy which is more marked in the lower limbs. Involvement of the respiratory system is common. A new treatment with intravenous enzyme replacement ( Myozyme) is now available. At present, there is only limited data available regarding its efficacy in the treatment of the adult form of Pompe's disease. CASE REPORT: A 67-year-old lady with Pompe's disease and known severe respiratory compromise due to involvement of the respiratory muscles had had recurrent emergency admissions with respiratory failure. After only a few weeks of treatment with intravenous enzyme replacement with Myozyme, significant improvement in her respiratory function was noticed. Following a total length of treatment of 7 months, her arterial blood gas results on room air had almost returned to normal. CONCLUSION: A glycogen storage disorder (type II) should be excluded in all adult patients with a slowly progressive weakness involving pelvic and thigh muscles even when respiratory involvement is not present. In addition to supportive treatment, a new enzyme replacement therapy for patients with late-onset disease has now become available which shows promising results.
|
Authors | Tobias Merk, Thomas Wibmer, Christian Schumann, Stefan Krüger |
Journal | Medizinische Klinik (Munich, Germany : 1983)
(Med Klin (Munich))
Vol. 102
Issue 7
Pg. 570-3
(Jul 15 2007)
ISSN: 0723-5003 [Print] Germany |
Vernacular Title | Schwere chronische respiratorische Insuffizienz bei adulter Glykogenose Typ II (Morbus Pompe). Erfolgreiche Therapie mittels Enzymersatz. |
PMID | 17634875
(Publication Type: Case Reports, English Abstract, Journal Article)
|
Chemical References |
- GAA protein, human
- alpha-Glucosidases
|
Topics |
- Aged
- Emergencies
- Female
- Glycogen Storage Disease Type II
(drug therapy)
- Humans
- Infusions, Intravenous
- Respiratory Insufficiency
(drug therapy)
- Treatment Outcome
- alpha-Glucosidases
(therapeutic use)
|